Anastomosis Devices Market Report 2026

Anastomosis Devices Market Overview

• Anastomosis Devices market size has reached to $3.86 billion in 2025 • Expected to grow to $5.64 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Surge In Surgical Procedures Drives Anastomosis Device Market Growth • Market Trend: Major Companies Redefine Anastomosis Devices With Technological Advancements • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anastomosis Devices Market?

Anastomosis devices are disposable or reusable instruments that establish an inverted or everted tissue closure secured by two or more rows of B-shaped stainless steel, titanium, or occasionally absorbable staples. It used to remove tissues that are diseased in the body without the leakage of body fluids. The main types of anastomosis devices are surgical staplers, surgical sutures, surgical sealants and adhesives, and automated suturing. Surgical staplers refer to tools that are utilized for closing significant surgical wounds or incisions on a patient's scalp or skin, which are used for applying staples to various tissues inside the body during surgery. They are disposable and reusable and are used for cardiovascular and thoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, and others. These are applied in hospitals, ambulatory surgery centers, and others.

What Is The Anastomosis Devices Market Growth Forecast?

The anastomosis devices market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for robotic surgical systems, rising focus on faster patient recovery outcomes, expansion of advanced surgical training programs, increasing adoption of disposable surgical devices, technological advancements in automated suturing. Major trends in the forecast period include increasing adoption of automated anastomosis devices, rising use of bioabsorbable sutures and staples, growing preference for minimally invasive surgical closure, expansion of robotic-assisted suturing systems, enhanced focus on leak-prevention technologies.

What Is The Driver Of The Anastomosis Devices Market?

The growth in surgical procedures is expected to propel the growth of the anastomosis device market going forward. Surgical procedures refer to any medical practice in which an incision is made on a person's body. The rise in surgical procedures is fueled by increasing demand for medical interventions and cosmetic surgeries. Anastomosis devices support this shift by enabling surgeons to connect two body portions, such as blood vessels or intestines, efficiently and safely during operations. For instance, in May 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, there were 778,500 patients were admitted for surgery from public hospital elective surgery waiting lists in 2023-24, a 5.8% increase compared with 2022-23. Therefore, the growth in surgical procedures is driving the growth of the anastomosis device industry.

Key Players In The Global Anastomosis Devices Market

Major companies operating in the anastomosis devices market are Medtronic plc, B. Braun Melsungen AG, Johnson & Johnson Services Inc., Boston Scientific Corp., Baxter International Inc., Meril Life Sciences Pvt. Ltd., Becton Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Getinge AB, LivaNova plc, Stryker Corporation, ConMed Corporation, Grena Ltd., Microline Surgical Inc., Scanlan International Inc., Innovia Medical, Genesee BioMedical Inc., EndoEvolution LLC, Novare Surgical Systems Inc., Dextera Surgical Inc., Intuitive Surgical Inc., Artivion Inc., CryoLife Inc., Cardica Inc., Vascular Graft Solutions Ltd., LifeNet Health Inc.

Global Anastomosis Devices Market Trends and Insights

Major companies operating in the anastomosis devices market are focusing on developing innovative surgical solutions such as advanced stapling technologies to improve surgical outcomes and enhance patient safety. Advanced stapling technologies are designed to reduce complications such as leaks at the staple line, ensuring the integrity of tissue closures and supporting faster, safer recovery. For instance, in May 2024, Ethicon, a US-based medical device company, launched the ECHELON LINEAR Cutter, a groundbreaking surgical stapler designed to enhance surgical outcomes by significantly reducing the risk of leaks at the staple line. This innovative device is reported to deliver 47% fewer leaks compared to traditional staplers, which can help mitigate potential complications during and after surgical procedures. The primary aim of the ECHELON linear cutter is to minimize the incidence of leaks at the staple line, which is crucial for maintaining the integrity of tissue closures. Leaks can lead to serious complications, including infections and extended recovery times.

What Are Latest Mergers And Acquisitions In The Anastomosis Devices Market?

In March 2024, Advanced Medical Solutions PLC, a UK-based medical technology company acquired Peters Surgical for an undisclosed amount. With this acquisition, Advanced Medical Solutions PLC aims to expand its presence in the operating room, increase its product portfolio and sales, enhance direct selling capabilities, and strengthen its global industrial footprint. Peters Surgical is a France-based medical technology company that specializes in surgical closure devices.

What Defines the Anastomosis Devices Market?

The anastomosis devices market consists of sales of cannula, robotics, and incision devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anastomosis Devices Market Report 2026?

The anastomosis devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anastomosis devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.